Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress Life Science Investing
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Life Science Investing
Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Life Science Investing
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference Life Science Investing
Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses Life Science Investing
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences Pharmaceutical Investing
Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update Life Science Investing
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance Medical Device Investing
Medtronic Announces Strategic Partnership with Cornerstone Robotics to Further Expand Global Access to Robotic-Assisted Surgery Medical Device Investing
Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR Medical Device Investing
